Incyte Partners With Penn on Cancer Immunotherapy Research – Genetic Engineering & Biotechnology News
Business Wire |
Incyte Partners With Penn on Cancer Immunotherapy Research
Genetic Engineering & Biotechnology News Incyte said today it will partner with the Abramson Cancer Center at the University of Pennsylvania on research into cancer biology and immunotherapy. Through the collaboration, whose value was not disclosed, Penn investigators will study novel … Incyte Corporation: Incyte Announces Oncology Research Alliance with the Abramson Cancer Center at the University … |
